Bridgebio Oncology Therapeutics, Inc. · NASDAQ:BBOT
Citadel Advisors LLC's stake in Bridgebio Oncology Therapeutics, Inc. fell to 3.20% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Citadel Advisors LLC's stake in Bridgebio Oncology Therapeutics, Inc. fell to 3.20%, 2,528,762 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 3.20%
- Shares
- 2,528,762
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Citadel Advisors LLC | 3.20% | 2,528,762 |
| Citadel Advisors Holdings LP | 3.20% | 2,528,762 |
| Citadel GP LLC | 3.20% | 2,528,762 |
| Citadel Securities LLC | 0% | 9,380 |
| Citadel Securities Group LP | 0% | 9,380 |
| Citadel Securities GP LLC | 0% | 9,380 |
| Kenneth Griffin | 3.20% | 2,538,142 |